| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 20 |
| 1 | AZATHIOPRINE | 18 |
| 2 | FUROSEMIDE | 18 |
| 3 | METHOTREXATE SODIUM | 17 |
| 4 | PREDNISONE | 17 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 6 | TACROLIMUS OINTMENT 0.1% | 17 |
| 7 | ACETAMINOPHEN | 16 |
| 8 | METHOTREXATE | 16 |
| 9 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 1 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 2 | STREPTOMYCIN | 2 | 0.0017 |
| 3 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID | 1 | 0.0016 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 10 | 0.0013 |
| 5 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 6 | OXAPROZIN | 1 | 0.0011 |
| 7 | RIFAMPICIN | 10 | 0.0010 |
| 8 | EFAVIRENZ | 11 | 0.0010 |
| 9 | THIOGUANINE | 2 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0005 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 6 | Antimycobacterial [EPC] | 6 | 0.0002 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Macrolide Antimicrobial [EPC] | 12 | 0.0002 |
| 9 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |